862 related articles for article (PubMed ID: 17727777)
21. Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and thrombospondin-1 (TSP-1) expression in urothelial carcinomas.
Donmez G; Sullu Y; Baris S; Yildiz L; Aydin O; Karagoz F; Kandemir B
Pathol Res Pract; 2009; 205(12):854-7. PubMed ID: 19762163
[TBL] [Abstract][Full Text] [Related]
22. [Expression of MMP-9 and MMP-9 mRNA in gastric carcinoma and its correlation with angiogenesis].
Wang L; Zhang LH; Li YL; Li YL; Liu Z
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):782-6. PubMed ID: 12899759
[TBL] [Abstract][Full Text] [Related]
23. Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.
Hao L; Zhang C; Qiu Y; Wang L; Luo Y; Jin M; Zhang Y; Guo TB; Matsushima K; Zhang Y
Cancer Lett; 2007 Aug; 253(1):34-42. PubMed ID: 17306924
[TBL] [Abstract][Full Text] [Related]
24. [Expressions of vascular endothelial growth factor C and matrix metalloproteinases-2 and prognosis of non-small cell lung carcinoma].
Zhang HZ; Wei YP; Li HG; Wang M; Liu JG; Wu C
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1307-10. PubMed ID: 16982442
[TBL] [Abstract][Full Text] [Related]
25. [Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour].
Gao GL; Liu LD; Zou XS; Chen WX
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):34-8. PubMed ID: 17331419
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor expression in progression of cervical cancer: correlation with thymidine phosphorylase expression, angiogenesis, tumor cell proliferation, and apoptosis.
Fujiwaki R; Hata K; Iida K; Maede Y; Miyazaki K
Anticancer Res; 2000; 20(2B):1317-22. PubMed ID: 10810442
[TBL] [Abstract][Full Text] [Related]
27. [Expression and significance about VEGF, KDR, MMP-1, and transcription factor Ets-1 in human cervical carcinoma].
Xu FL; Li YL; Wang ZD; Feng YJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):396-400. PubMed ID: 12974081
[TBL] [Abstract][Full Text] [Related]
28. Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer.
Sato F; Shimada Y; Watanabe G; Uchida S; Makino T; Imamura M
Br J Cancer; 1999 Jul; 80(9):1366-72. PubMed ID: 10424737
[TBL] [Abstract][Full Text] [Related]
29. [Expression of hypoxia-inducible factor-1alpha and vessel endothelial growth factor in esophageal squamous cell carcinoma and clinico-pathological significance thereof].
Yu ZT; Zhao HF; Shang XB
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2465-9. PubMed ID: 19080625
[TBL] [Abstract][Full Text] [Related]
30. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
Wu H; Li Y; Zhu G; Zhang L; Zhang X; He X
Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):708-11. PubMed ID: 12133473
[TBL] [Abstract][Full Text] [Related]
31. [Expression of angiogenesis-related factors in invasive breast cancer and its clinical significance].
Wang XB; Yang QX; Pei XJ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):860-3. PubMed ID: 16793622
[TBL] [Abstract][Full Text] [Related]
32. [Correlation of expression of vascular endothelial growth factor and matrix matalloproteinase-2 to invasion of ovarian tumor cells in vitro].
Zhang AL; Wang SX; Lu YP; Li J; Wang CY; Ma D
Ai Zheng; 2002 Mar; 21(3):263-6. PubMed ID: 12451991
[TBL] [Abstract][Full Text] [Related]
33. [Expression and clinical impact of vascular endothelial growth factor and matrix metalloproteinase-2 in hepatocellular carcinoma].
Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):285-8. PubMed ID: 16875630
[TBL] [Abstract][Full Text] [Related]
34. RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer.
Oshikiri T; Hida Y; Miyamoto M; Hashida H; Katoh K; Suzuoki M; Nakakubo Y; Hiraoka K; Shinohara T; Itoh T; Kondo S; Katoh H
Br J Cancer; 2001 Dec; 85(12):1922-7. PubMed ID: 11747335
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array.
Wang PH; Ko JL; Tsai HT; Yang SF; Han CP; Lin LY; Chen GD
Gynecol Oncol; 2008 Mar; 108(3):533-42. PubMed ID: 18177928
[TBL] [Abstract][Full Text] [Related]
36. Pitfalls in immunohistochemical validation of tumor marker expression--exemplified in invasive cancer of the uterine cervix.
Hellberg D; Tot T; Stendahl U
Gynecol Oncol; 2009 Jan; 112(1):235-40. PubMed ID: 18976801
[TBL] [Abstract][Full Text] [Related]
37. Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer.
Shou Y; Hirano T; Gong Y; Kato Y; Yoshida K; Ohira T; Ikeda N; Konaka C; Ebihara Y; Zhao F; Kato H
Br J Cancer; 2001 Nov; 85(11):1706-12. PubMed ID: 11742492
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor, matrix metalloproteinases, and cyclooxygenase-2 influence prognosis of uterine cervical cancer in young women.
Noriyuki M; Sumi T; Zhi X; Misugi F; Nobeyama H; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
Int J Oncol; 2007 Sep; 31(3):531-6. PubMed ID: 17671679
[TBL] [Abstract][Full Text] [Related]
39. [Expression and clinical significance of vascular endothelial growth factor C and D in nasopharyngeal carcinoma].
Zhao GG; Xiang XJ; He YJ
Ai Zheng; 2007 Jan; 26(1):90-5. PubMed ID: 17222375
[TBL] [Abstract][Full Text] [Related]
40. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
